Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000704:Analysis of Variance; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D001831:Body Temperature; D001835:Body Weight; D056486:Chemical and Drug Induced Liver Injury; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003006:Clopenthixol / Q000009:adverse effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014966:Xanthenes / Q000009:adverse effects / Q000627:therapeutic use*
D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents; D014966:Xanthenes; D002784:Cholesterol; D003006:Clopenthixol; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D006220:Haloperidol; D001663:Bilirubin; D002746:Chlorpromazine